MicroPort CardioFlow Wins Shareholder Approval for Share Consolidation Effective 24 February
I'm PortAI, I can summarize articles.
MicroPort CardioFlow Medtech Corp. has received shareholder approval for a share consolidation, reducing issued shares from approximately 6.37 billion to about 1.27 billion. This consolidation will take effect on 24 February 2026, aiming to enhance trading efficiency and price perception. Existing blue share certificates will remain valid but not for trading after new light-gold certificates are issued. The company will also adjust share options accordingly. The latest analyst rating for the stock (HK:2160) is a Sell with a price target of HK$0.74.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments